The BNT162b2 mRNA vaccine against SARS-CoV-2 reprograms both adaptive and innate immune responses

Fohse, F. K.; Geckin, B.; Overheul, G. J.; van de Maat, J.; Kilic, G.; Bulut, O.; Hoogerwerf, J.; ten Oever, J.; Simonetti, E.; van de Veerdonk, F. L.; Joosten, L. A. B.; Haagmans, B. L.; van Crevel, R.; Li, Y.; van Rij, R. P.; GeurtsvanKessel, C.; de Jonge, M. I.; Dominguez-Andres, J.; Netea, M. G.

Fohse, F. K.; Geckin, B.; Overheul, G. J.; van de Maat, J.; Kilic, G.; Bulut, O.; Hoogerwerf, J.; ten Oever, J.; Simonetti, E.; van de Veerdonk, F. L.; Joosten, L. A. B.; Haagmans, B. L.; van Crevel, R.; Li, Y.; van Rij, R. P.; GeurtsvanKessel, C.; de Jonge, M. I.; Dominguez-Andres, J.; Netea, M. G..

European Journal of Immunology ; 51:90-90, 2021.

Article in English | Web of Science | ID: covidwho-1717003

Keywords

Adjuvants and vaccines; innate host defence; innate immunity; viral; infections; Immunology

Search on Google

XML

Collection: Databases of international organizations Database: Web of Science Topics: Vaccines Language: English Journal: European Journal of Immunology Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML